• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

轻度至中度冠状动脉狭窄的诊断与管理的当前进展

Current Advancements in the Diagnosis and Management of Mild-to-moderate Coronary Stenosis.

作者信息

Guo Cuimei, Gao Haizhu, Bian Xinxin, Lin Nan, Gan Lijun, Chen Xueying

机构信息

Colleague of Clinical Medicine, Jining Medical University, 272067 Jining, Shandong, China.

Department of Cardiology, Shandong Key Laboratory for Diagnosis and Treatment of Cardiovascular Diseases, Jining Key Laboratory of Precise Therapeutic Research of Coronary Intervention, Affiliated Hospital of Jining Medical University, 272029 Jining, Shandong, China.

出版信息

Rev Cardiovasc Med. 2025 Aug 27;26(8):38822. doi: 10.31083/RCM38822. eCollection 2025 Aug.

DOI:10.31083/RCM38822
PMID:40927076
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12415760/
Abstract

Coronary heart disease (CHD) is associated with increased morbidity and mortality. Acute cardiovascular events frequently occur in patients with coronary artery stenoses exceeding 70%. Although coronary revascularization can significantly improve ischemic symptoms, the inflection point for reducing mortality from CHD has yet to be reached. Therefore, the prevention and treatment of mild-to-moderate coronary artery stenosis should be given significant attention to more effectively reduce the incidence and mortality of acute events from CHD. Subsequently, a stenosis of less than 70% is used to characterize the incidence of mild to moderate coronary artery stenosis. While acute cardiovascular events caused by soft plaque and plaque rupture may not have a significant impact on hemodynamics, these events are detrimental and result in increased mortality. This review summarizes the methods available for detecting mild-to-moderate coronary artery stenoses, assessing risk, and understanding the mechanisms underlying adverse events. Moreover, this review proposes intervention strategies for preventing and treating mild to moderate coronary stenosis.

摘要

冠心病(CHD)与发病率和死亡率的增加相关。急性心血管事件频繁发生于冠状动脉狭窄超过70%的患者中。尽管冠状动脉血运重建可显著改善缺血症状,但降低冠心病死亡率的拐点尚未达到。因此,应高度重视轻至中度冠状动脉狭窄的防治,以更有效地降低冠心病急性事件的发生率和死亡率。随后,小于70%的狭窄用于表征轻至中度冠状动脉狭窄的发生率。虽然由软斑块和斑块破裂引起的急性心血管事件可能对血流动力学没有显著影响,但这些事件是有害的,并会导致死亡率增加。本综述总结了可用于检测轻至中度冠状动脉狭窄、评估风险以及了解不良事件潜在机制的方法。此外,本综述提出了预防和治疗轻至中度冠状动脉狭窄的干预策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a2e/12415760/23a3829eb634/2153-8174-26-8-38822-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a2e/12415760/23a3829eb634/2153-8174-26-8-38822-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a2e/12415760/23a3829eb634/2153-8174-26-8-38822-g1.jpg

相似文献

1
Current Advancements in the Diagnosis and Management of Mild-to-moderate Coronary Stenosis.轻度至中度冠状动脉狭窄的诊断与管理的当前进展
Rev Cardiovasc Med. 2025 Aug 27;26(8):38822. doi: 10.31083/RCM38822. eCollection 2025 Aug.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Exercise-based cardiac rehabilitation for coronary heart disease.基于运动的冠心病心脏康复。
Cochrane Database Syst Rev. 2021 Nov 6;11(11):CD001800. doi: 10.1002/14651858.CD001800.pub4.
4
Carotid Artery Surgery颈动脉手术
5
[Guidelines for the prevention and management of bronchial asthma (2024 edition)].[支气管哮喘防治指南(2024年版)]
Zhonghua Jie He He Hu Xi Za Zhi. 2025 Mar 12;48(3):208-248. doi: 10.3760/cma.j.cn112147-20241013-00601.
6
Management of urinary stones by experts in stone disease (ESD 2025).结石病专家对尿路结石的管理(2025年结石病专家共识)
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.
7
Hemophilia B乙型血友病
8
A systematic review and economic evaluation of statins for the prevention of coronary events.他汀类药物预防冠状动脉事件的系统评价与经济学评估
Health Technol Assess. 2007 Apr;11(14):1-160, iii-iv. doi: 10.3310/hta11140.
9
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].[容量与健康结果:来自系统评价和意大利医院数据评估的证据]
Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.

本文引用的文献

1
FFR-Negative Nonculprit High-Risk Plaques and Clinical Outcomes in High-Risk Populations: An Individual Patient-Data Pooled Analysis From COMBINE (OCT-FFR) and PECTUS-obs.高风险人群中血流储备分数阴性的非罪犯高危斑块与临床结局:来自COMBINE(光学相干断层扫描-血流储备分数)和PECTUS-obs的个体患者数据汇总分析
Circ Cardiovasc Interv. 2025 Feb;18(2):e014667. doi: 10.1161/CIRCINTERVENTIONS.124.014667. Epub 2025 Jan 22.
2
Diagnostic Performance and Clinical Impact of Photon-Counting Detector Computed Tomography in Coronary Artery Disease.光子计数探测器计算机断层扫描在冠状动脉疾病中的诊断性能及临床影响
J Am Coll Cardiol. 2025 Feb 4;85(4):339-348. doi: 10.1016/j.jacc.2024.10.069. Epub 2024 Oct 28.
3
Predictors for Vulnerable Plaque in Functionally Significant Lesions.
功能显著病变中易损斑块的预测因素
JACC Cardiovasc Imaging. 2025 Feb;18(2):195-206. doi: 10.1016/j.jcmg.2024.07.021. Epub 2024 Sep 11.
4
2024 ESC Guidelines for the management of chronic coronary syndromes.2024年欧洲心脏病学会慢性冠状动脉综合征管理指南
Eur Heart J. 2024 Sep 29;45(36):3415-3537. doi: 10.1093/eurheartj/ehae177.
5
Diagnostic Performance of Fractional Flow Reserve Derived From Coronary CT Angiography: The ACCURATE-CT Study.基于冠状动脉CT血管造影的血流储备分数的诊断性能:ACCURATE-CT研究
JACC Cardiovasc Interv. 2024 Sep 9;17(17):1980-1992. doi: 10.1016/j.jcin.2024.06.027. Epub 2024 Aug 21.
6
Influence of Pathophysiologic Patterns of Coronary Artery Disease on Immediate Percutaneous Coronary Intervention Outcomes.冠状动脉疾病病理生理模式对即刻经皮冠状动脉介入治疗结局的影响。
Circulation. 2024 Aug 20;150(8):586-597. doi: 10.1161/CIRCULATIONAHA.124.069450. Epub 2024 May 14.
7
Preventive percutaneous coronary intervention versus optimal medical therapy alone for the treatment of vulnerable atherosclerotic coronary plaques (PREVENT): a multicentre, open-label, randomised controlled trial.预防性经皮冠状动脉介入治疗与单纯最佳药物治疗治疗易损动脉粥样硬化性冠状动脉斑块(PREVENT):一项多中心、开放标签、随机对照试验。
Lancet. 2024 May 4;403(10438):1753-1765. doi: 10.1016/S0140-6736(24)00413-6. Epub 2024 Apr 8.
8
The Ability of Near-Infrared Spectroscopy to Identify Vulnerable Patients and Plaques: A Systematic Review and Meta-Analysis.近红外光谱识别易损患者和斑块的能力:一项系统评价和荟萃分析。
Heart Fail Clin. 2024 Jan;20(1):101-112. doi: 10.1016/j.hfc.2023.06.004.
9
Significance of Intra-plaque Hemorrhage for the Development of High-Risk Vulnerable Plaque: Current Understanding from Basic to Clinical Points of View.易损斑块内斑块出血的意义:从基础到临床观点的当前认识。
Int J Mol Sci. 2023 Aug 27;24(17):13298. doi: 10.3390/ijms241713298.
10
Evidence of an anti-inflammatory effect of PCSK9 inhibitors within the human atherosclerotic plaque.在人类动脉粥样硬化斑块中发现 PCSK9 抑制剂的抗炎作用。
Atherosclerosis. 2023 Aug;378:117180. doi: 10.1016/j.atherosclerosis.2023.06.971. Epub 2023 Jun 29.